New research indicates that patients who discontinue new weight-loss injections like Wegovy and Mounjaro may regain reduced body mass far faster than those who stop conventional diet and exercise programs.
Research printed in a prominent medical journal demonstrates that while overweight individuals frequently drop substantial amounts of their total mass while using the jabs, the weight comes back at an average rate of nearly a kilo each month after stopping.
"Users buying such medications need to be cognizant of the danger of quick weight regain when the medication ends," cautioned researcher Dr. Susan Jebb.
Such speed of recovery suggests a reversion to original mass in about one and a half years.
Analyzing Therapies
The analysis, which reviewed dozens of trials involving thousands of patients, compared the outcomes of the injectable medications with conventional dieting.
Scientists point out that people who lose weight through lifestyle changes alone generally see a slower creep back—around 100 grams monthly—post-intervention.
Explaining the Fast Rebound
Nutrition scientists believe the mode of action of the injections accounts for the accelerated rebound.
The injections mimic a natural hormone called GLP-1, which helps regulate appetite.
"Artificially providing GLP-1 concentrations far above than the body's typical production may cause the body to produce less of its endogenous GLP-1, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' leads to appetite is uncontrolled, making overeating much more probable."
An Ongoing Issue?
Health authorities advise the jabs for people with obesity-related medical conditions, alongside prescribed lifestyle changes.
Professionals argue that, due to the significant potential of weight regain, the therapy might need to be life-long.
This opinion is supported by pharmaceutical companies, who state that the findings "emphasize the long-term nature of excess weight," comparing it to managing diseases like hypertension.
Patient Experiences
Users who have stopped the medication explain a intense return of appetite.
"I experienced a switch that goes on and you become ravenous," described an individual.
This difficulty is worsened if users have not adopted permanent lifestyle or habit changes during treatment.
Significant Interest
Recent estimates indicate that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial.
- Use is more common among females compared to men.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion access the medications through private healthcare rather than public health services.
In conclusion, experts caution that while GLP-1 drugs are powerful agents for shedding pounds, they are not a permanent cure and lasting health benefits relies on combined lifestyle support.
